Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy

Thyroid

Volumn 18, Issue 9, 2008, Pages 983-988

  Smith, Terry J ^a,b,c   Tsai, Chieh Chih ^a   Shih, Mei Ju ^a   Tsui, Shanli ^a   Chen, Beiling ^a   Han, Rui ^a   Naik, Vibha ^a   King, Chris S ^a   Press, Chris ^a   Kamat, Shweta ^a   Goldberg, Robert A ^b   Phipps, Richard P ^d   Douglas, Raymond S ^a,b,c   Gianoukakis, Andrew G ^a,c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b JULES STEIN EYE INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 15 LIPOXYGENASE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 4; PROSTAGLANDIN E2; SOMATOMEDIN C;

CELL DIFFERENTIATION; CELL POPULATION; CONFERENCE PAPER; ENDOCRINE OPHTHALMOPATHY; FIBROBLAST; GRAVES DISEASE; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL DIFFERENTIATION; CHEMOTACTIC FACTORS; DINOPROSTONE; FIBROBLASTS; GRAVES OPHTHALMOPATHY; HUMANS; INFLAMMATION; LYMPHOCYTES; MODELS, BIOLOGICAL; MUSCLES; ORBIT; PHENOTYPE; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

EID: 51849137026     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0404     Document Type: Conference Paper

References (54)

1. Kazim M, Goldberg RA, Smith TJ 2002 Insights into the pathogenesis of thyroid associated orbitopathy: evolving rationale for therapy. Arch Ophthalmol 120:380-386.
2. Smith TJ 2002 Fibroblast biology in thyroid diseases. Curr Opin Endocrinol Diabetes 9:393-400.
3. Prabhakar BS, Bahn RS, Smith TJ 2003 Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 24:802-835.
4. Smith TJ, Bahn RS, Gorman CA 1989 Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 10:366-391.
5. Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, Eagle RC 1984 Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology 91:1411-1419.
6. Sorisky A, Pardasani D, Gagnon A, Smith TJ 1996 Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. J Clin Endocrinol Metab 81:3428-3431.
7. - subpopulations exhibit distinct phenotypes. Eur J Immunol 32:477-485.
8. de Carli M, D'Elios MM, Mariotti S, Marcocci C, Pinchera A, Ricci M, Romagnani S, del Prete G 1993 Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J Clin Endocrinol Metab 77:1120-1124.
9. Grubeck-Loebenstein B, Trieb K, Sztankay A, Holter W, Anderl H, Wick G 1994 Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. J Clin Invest 93:2738-2743.
10. Heufelder AE, Bahn RS 1993 Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest 23:10-17.
11. Wakelkamp IM, Gerding MN, Van Der Meer JW, Prummel MF, Wiersinga WM 2000 Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy. Clin Exp Immunol 121:453-457.
12. Hiromatsu Y, Yang D, Bednarczuk T, Miyake I, Nonaka K, Inoue Y 2000 Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 85:1194-1199.
13. Molnár I, Balázs C 1997 High circulating IL-6 level in Graves' ophthalmopathy. Autoimmunity 25:91-96.
14. Antonelli A, Rotondi M, Ferrari SM, Fallahi P, Romagnani P, Franceschini SS, Serio M, Ferrannini E 2006 Interferon-γ-inducible α-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-γ agonists. J Clin Endocrinol Metab 91: 614-620.
15. Smith TJ, Wang H-S, Evans CH 1995 Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts. Am J Physiol Cell Physiol 268:C382-C388.
16. Sempowski GD, Rozenblit J, Smith TJ, Phipps RP 1998 Human orbital fibroblasts are activated through CD40 to induce pro-inflammatory cytokine production. Am J Physiol Cell Physiol 274:C707-C714.
17. Cao HJ, Wang H-S, Zhang Y, Lin H-Y, Phipps RP, Smith TJ 1998 Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression: insights into potential pathogenic mechanisms of thyroid associated ophthalmopathy. J Biol Chem 273:29615-29625.
18. Cao HJ, Smith TJ 1999 Leukoregulin up-regulation of prostaglandin endoperoxide H synthase-2 expression in human orbital fibroblasts. Am J Physiol Cell Physiol 277:C1075-C1085.
19. Kaback LA, Smith TJ 1999 Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1β in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 84:4079-4084.
20. Toussirot E, Wendling D 2004 The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview. Expert Opin Pharmacother 5:581-594.
21. Wang H-S, Cao HJ, Winn VD, Rezanka LJ, Frobert Y, Evans CH, Sciaky D, Young DA, Smith TJ 1996 Leukoregulin induction of prostaglandin endoperoxide H synthase-2 in human orbital fibroblasts: an in vitro model for connective tissue inflammation. J Biol Chem 271:22718-22728.
22. 2 synthase expression. J Biol Chem 277:16355-16364.
23. Chen B, Tsui S, Smith TJ 2005 IL-1β induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotype attribute relevant to thyroidassociated ophthalmopathy. J Immunol 175:1310-1319.
24. Sciaky D, Brazer W, Center DM, Cruikshank WW, Smith TJ 2000 Cultured human fibroblasts express constitutive IL-16 mRNA: cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism. J Immunol 164:3806-3814.
25. Smith TJ, Hoa N 2004 Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, IGF-1 receptor. J Clin Endocrinol Metab 89:5076-5080.
26. Weigel PH, Hascall VC, Tammi M 1997 Hyaluronan synthases. J Biol Chem 272:13997-14000.
27. Spicer AP, Kaback LA, Smith TJ, Seldin MF 1998 Molecular cloning and characterization of the human and mouse UDPglucose dehydrogenase genes. J Biol Chem 273:25117-25124.
28. Young DA, Evans CH, Smith TJ 1998 Leukoregulin induction of protein expression in human orbital fibroblasts: evidence for anatomical-site-restricted cytokine-target cell interactions. Proc Natl Acad Sci USA 95:8904-8909.
29. Cao HJ, Han R, Smith TJ 2003 Robust induction of PGHS-2 by IL-1 in orbital fibroblasts results from low levels of IL-1 receptor antagonist expression. Am J Physiol Cell Physiol 284:C1429-C1437.
30. 2 on murine helper-T-cell lymphokines. Immunomethods 2:255-260.
31. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146:108-113.
32. Hu ZQ, Asano K, Seki H, Shimamura T 1995 An essential role of prostaglandin E on mouse mast cell induction. J Immunol 155:2134-2142.
33. 2 induces apoptosis in immature normal and malignant B lymphocytes. Clin Immunol Immunopathol 63:221-229.
34. Konuk EBY, Konuk O, Misirlioglu M, Menevse A, Unai M 2006 Expression of cyclooxygenase-2 in orbital fibroadipose connective tissues in Graves' ophthalmopathy patient. Eur J Endocrinol 155:681-685.
35. H2 cytokines. J Biol Chem 281:18296-18306.
36. Smith TJ, Koumas L, Gagnon A, Bell A, Sempowski GD, Phipps RP, Sorisky A 2002 Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 87:385-392.
37. Valyasevi RW, Harteneck DA, Dutton CM, Bahn RS 2002 Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ (PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 87:2352-2358.
38. Zhang L, Baker G, Janus D, Paddon CA, Fuhrer D, Ludgate M 2006 Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Invest Ophthalmol Vis Sci 47:5197-5203.
39. Feldon SE, O'loughlin CW, Ray DM, Landskroner-Eiger S, Seweryniak KE, Phipps RP 2006 Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. Am J Pathol 169:1183-1193.
40. Smith TJ, Sempowski GD, Wang H-S, Del Vecchio PJ, Lippe SD, Phipps RP 1995 Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts. J Clin Endocrinol Metab 80:2620-2625.
41. Noden DM 1983 The role of the neural crest in patterning of avian cranial skeletal, connective, and muscle tissues. Dev Biol 96:144-165.
42. Noden DM 1982 Periocular mesenchyme: neural crest and mesodermal interactions. In: Jakobiec FA (ed) Ocular Anatomy, Embryology and Teratology, vol. 97. Harper and Row, Philadelphia, p 119.
43. Stahl PJ, Felsen D 2001 Transforming growth factor-β, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease. Am J Pathol 159:1187-1192.
44. Strutz F, Müller GA, Neilson EG 1996 Transdifferentiation: a new angle on renal fibrosis. Exp Nephrol 4:267-270.
45. Jinde K, Nikolic-Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC, Lan HY 2001 Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 38:761-769.
46. Nightingale J, Patel S, Suzuki N, Buxton R, Takagi KI, Suzuki J, Sumi Y, Imaizumi A, Mason RM, Zhang Z 2004 Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. J Am Soc Nephrol 15:21-32.
47. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM 2004 Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114:438-446.
48. Center DM, Kornfeld H, Cruikshank WW 1997 Interleukin-16. Int J Biochem Cell Biol 29:1231.
49. Pritchard J, Horst N, Cruikshank W, Smith TJ 2002 Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol 168:942-950.
50. Pritchard J, Tsui S, Horst N, Cruikshank WW, Smith TJ 2004 Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves' disease, express high levels of IL-16 when treated with immunoglobulins against the IGF-1 receptor. J Immunol 173:3564-3569.
51. Feldon SE, Park DJ, O'Loughlin CW, Nguyen VT, Landskroner-Eiger S, Chang D, Thatcher TH, Phipps RP 2005 Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy. Invest Ophthalmol Vis Sci 46:3913-3921.
52. 2 and hyaluronan synthesis. Endocrinology 140:3518-3525.
53. Bossowski A, Urban M, Stasiak-Barmuta A 2003 Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naïve (CD45RA) T cells in children with immune and non-immune thyroid diseases. J Pediatr Endocrinol Metab 16:63-70.
54. Douglas RS, Gianoukakis AG, Kamat S, Smith TJ 2007 Aberrant expression of the IGF-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis. J Immunol 178:3281- 3287.